GlaxoSmithKline Pharmaceuticals is currently trading at Rs. 2481.00, up by 181.00 points or 7.87% from its previous closing of Rs. 2300.00 on the BSE.
The scrip opened at Rs. 2293.95 and has touched a high and low of Rs. 2550.00 and Rs. 2285.00 respectively. So far 29302 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2522.00 on 07-May-2013 and a 52 week low of Rs. 1916.00 on 04-Jul-2012.
Last one week high and low of the scrip stood at Rs. 2315.00 and Rs. 2240.00 respectively. The current market cap of the company is Rs. 20752.24 crore.
The promoters holding in the company stood at 50.67% while Institutions and Non-Institutions held 34.17% and 15.16% respectively.
GlaxoSmithKline Pharmaceuticals’ promoter is reportedly planning to increase stake in the company. The parent company will hike the stake through voluntary open offer. The promoters holding in the company stood at 50.67% while Institutions and Non-Institutions held 34.17% and 15.16% in the company, respectively.
GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.
